Timeline: Research-Idea-Support-Goal
  • 2018

    GNL Celebrates 10th Anniversary (November 2018)

  • 2017

    Biodefense Strategy for U.S. Becomes Major Priority; GNL Has Seat at the Policy Table.

  • 2016

    UT Chancellor William McRaven Makes National Security, Including Biosecurity, a UT System Priority

  • 2015

    GNL’s Expertise in Vector Borne Diseases, including Chikungunya and Zika Play Major Role in International Research

  • 2014

    West African Ebola Outbreak Puts GNL and Ebola Research at Forefront of Infectious Disease Attention

  • 2013

    Vaccine and Other Medical Countermeasures Are Major Focus at GNL

  • 2010

    GNL Begins Increasing Capacity with BSL2, BSL3 and BSL4 Labs all Increasing Research

  • 2008

    Galveston National Laboratory Opened

  • 2006

    UC7 Galveston National Laboratory Operations

  • 2005

    Galveston National Laboratory ground-breaking

  • 2004

    Robert E. Shope BSL-4 Laboratory / John Sealy Pavilion opens Institute for Human Infections & Immunity

  • 2003

    Western Regional Center of Excellence (RCE)

    UC6 Galveston National Laboratory (NBL) awards

    NHLBI RSV Proteomics Center

  • 2002

    NIAID Hepatitis C Antiviral Contract

    Shope BSL-4 Laboratory ground-breaking

    Anthrax attacks

  • 2001

    UTMB Center for Biodefense

    UT System approves BSL-4 lab construction

  • 2000

    Sealy Center for Vaccine Development

  • 1997

    DARPA Biodefense Grant

    WHO Collaborating Center for Arbovirus and HF Virus Research

    NIAID Cooperative Hepatitis C Research Center

  • 1995

    WHO Collaborating Center for Tropical Diseases World Reference Center for Arboviruses Medical Mycology Reference Center established

  • 1994

    Center for Tropical Diseases